Publications by authors named "David Cano-Rodriguez"

Claim this Profile
R
RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis.
Maria Laura Tognoli, Nikola Vlahov, Sander Steenbeek, Anna M Grawenda, Michael Eyres, David Cano-Rodriguez

EMBO J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-expressing Epigenetically Silenced Genes by Inducing DNA Demethylation Through Targeting of Ten-Eleven Translocation 2 to Any Given Genomic Locus.
Julio Cesar Rendón, David Cano-Rodríguez, Marianne G Rots

Methods Mol Biol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCTN2: a novel tumor marker with oncogenic properties.
David Cano-Rodriguez, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Elisa De Camilli

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will.
David Cano-Rodriguez, Marianne G Rots

Curr Genet Med Rep· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner.
David Cano-Rodriguez, Rutger A F Gjaltema, Laura J Jilderda, Pytrick Jellema, Jelleke Dokter-Fokkens

Nat Commun· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis